Transvaginal ultrasound screening for ovarian cancer risk
Part of Cancer, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This study tests whether a transvaginal ultrasound can be used as a screening tool for ovarian cancer in women at higher risk. It may help find ovarian cancer earlier in people who have a strong family or personal cancer history.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman age 50 or older, or you are 25 or older with a specific cancer risk history
- You have either a family history of ovarian cancer (in someone over age 24) or a personal history of breast cancer
- You are well enough to do usual daily activities (ECOG score 0 to 2)
- You can have a transvaginal ultrasound safely and comfortably (including being able to position your body for it)
- You can understand the study and sign written consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well a blood test called CA-125, along with other markers and checkups, can detect ovarian cancer early. It’s for women considered low risk who will do regular blood tests and possibly a vaginal ultrasound if results suggest it.
This study is testing a new blood test that may help detect ovarian cancer earlier. Researchers want to see if it can tell the difference between people with ovarian cancer and those without it.
This study looks at whether pictures from a vaginal (transvaginal) ultrasound of a healthy ovary can help predict whether someone carries BRCA1 or BRCA2 gene changes. It may help identify people who could benefit from more genetic testing, without needing new ultrasound images.
This trial tests whether a nudge or reminder can help doctors refer patients with suspicious ovarian masses to a gynecologic oncologist. If you have a finding on an imaging test that suggests possible ovarian cancer, this study may help connect you with the right specialist.
This study collects tissue samples and medical information from people at higher risk for ovarian cancer or undergoing gynecologic surgery. Researchers use this data to develop better ways to detect and prevent ovarian cancer early.
This trial checks whether a “liquid biopsy,” a blood test, can help doctors tell apart different causes of a suspicious pelvic/ovarian mass and help with early detection. It may help avoid uncertainty before surgery by adding test results from blood along with imaging and standard markers.
Hear when a new Ovarian cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.